Applied Financial Statements From 2010 to 2024
| AMTIDelisted Stock | USD 0.33 0.00 0.00% |
Check Applied Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Molecular's main balance sheet or income statement drivers, such as , as well as many indicators such as . Applied financial statements analysis is a perfect complement when working with Applied Molecular Valuation or Volatility modules.
Applied |
Applied Molecular Transport Company Shares Owned By Insiders Analysis
Applied Molecular's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Applied Molecular Shares Owned By Insiders | 21.35 % |
Most of Applied Molecular's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Applied Molecular Transport is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 21.35% of Applied Molecular Transport are shares owned by insiders. This is 40.65% higher than that of the Biotechnology sector and 50.56% higher than that of the Health Care industry. The shares owned by insiders for all United States stocks is 111.6% lower than that of the firm.
Applied Molecular Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Applied Molecular's current stock value. Our valuation model uses many indicators to compare Applied Molecular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Applied Molecular competition to find correlations between indicators driving Applied Molecular's intrinsic value. More Info.Applied Molecular Transport is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Applied Molecular's earnings, one of the primary drivers of an investment's value.About Applied Molecular Financial Statements
Investors use fundamental indicators, such as Applied Molecular's revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Molecular's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. Applied Molecular operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 125 people.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Molecular check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Molecular's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |